{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-072025-04-072025-04-082025-04-082025-04-092025-04-092025-04-102025-04-102025-04-112025-04-112025-04-132025-04-13213211124433221100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-072025-04-072025-04-082025-04-082025-04-092025-04-092025-04-102025-04-102025-04-112025-04-112025-04-132025-04-13111222314433221100
Download SVG
Download PNG
Download CSV

ubs maintains buy rating for merck kgaa with target price of 190 euros

UBS has maintained a 'Buy' rating for Merck KGaA, setting a target price of 190 euros ahead of the Group's Capital Markets Day. Analyst Matthew Weston noted that the new targets align closely with consensus estimates, reflecting the company's strong position in pharmaceuticals and chemicals.
12:27 17.10.2024

UBS maintains neutral rating for Sartorius after mixed quarterly results

UBS has maintained a "Neutral" rating for Sartorius with a target price of 264 euros following the release of third-quarter figures. While the laboratory services provider's consolidated sales fell short of consensus estimates, its operating profit met expectations. The recovery in orders within the BPS division may positively influence the market.
11:41 17.10.2024

ubs rates sartorius neutral with target price of 264 euro

UBS has rated Sartorius as 'Neutral' with a target price of €264. The stock closed at €263.40, reflecting a 15.22% increase. Trading activity showed varied prices across different exchanges, with the highest at €268.30 on Hamburg and the lowest at €240.60 in Munich.
11:41 17.10.2024

ubs rates merck kgaa as buy with target price of 190 euro

UBS has rated Merck KGaA as 'Buy' with a target price of €190. The stock closed at €165.35 on October 17, reflecting a 7.23% increase from the previous day. Trading activity varied across platforms, with prices ranging from €159.40 to €177.00 throughout the day.
11:40 17.10.2024

UBS maintains buy rating for Merck KGaA with target price of 190 euros

UBS has maintained its "Buy" rating for Merck KGaA, setting a target price of 190 euros ahead of the Group's Capital Markets Day. Analyst Matthew Weston noted that the new targets align closely with consensus estimates, which had been previously indicated by the company.
11:40 17.10.2024

Zur Rose Group AG faces challenges in pharmaceutical distribution sector

Zur Rose Group AG, a Swiss pharmaceutical distribution company, operates through two divisions: Zur Rose, which focuses on wholesale medicine supply to healthcare providers, and DocMorris, which manages mail-order pharmacy sales. The company serves markets in Switzerland, Germany, and the Netherlands via subsidiaries including Zur Rose Suisse AG and DocMorris NV.
11:39 17.10.2024

UBS cuts DocMorris price target to 25 francs maintains sell rating

UBS has reduced its price target for DocMorris from 27 to 25 francs, maintaining a "Sell" rating. Analyst Sebastian Vogel noted that the online pharmacy's recent statements indicate a slowdown in growth for prescription drugs in the German market in the near term.
11:39 17.10.2024

just eat takeaway.com expands global online food delivery marketplace

Just Eat Takeaway.com N.V., headquartered in Amsterdam, is a prominent global online food delivery marketplace, connecting consumers with over 699,000 restaurant partners. The company operates in various regions, including North America, Northern Europe, the UK, Southern Europe, Australia, and New Zealand, offering a diverse range of food choices and delivery services.
11:39 17.10.2024

global market strategies amid renewed economic support from major economies

Policymakers in the U.S. and China are taking decisive steps to bolster economic growth, with the Fed initiating an easing cycle and China committing to support consumers. This shift in strategy signals a potential revival in private sector confidence, despite ongoing risks. Asset allocation is adjusting, favoring emerging markets and Asian credit, while U.S. Treasuries are downgraded. Caution remains due to geopolitical uncertainties and the possibility of disappointing Chinese policy outcomes.
11:10 17.10.2024

ubs downgrades moller maersk to neutral with target of 11000 kroner

UBS has downgraded A.P. Moller-Maersk from "Buy" to "Neutral," reducing the price target from 13,953 to 11,000 Danish kroner. Analyst Cristian Nedelcu noted that the shares face challenges due to concerns over medium-term overcapacity in the shipping sector and capital usage.
11:08 17.10.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.